miR-454 is down-regulated in osteosarcomas and suppresses cell proliferation and invasion by directly targeting c-Met
Author:
Affiliation:
1. Department of Orthopaedics; Shandong Provincial Hospital affiliated to Shandong University; Jinan 250021 China
2. Department of Health Care Center; Shandong Provincial Hospital affiliated to Shandong University; Jinan 250021 China
Publisher
Wiley
Subject
Cell Biology,General Medicine
Reference40 articles.
1. Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma;Hu;Oncotarget,2014
2. Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells;Bonuccelli;Oncotarget,2014
3. Overexpression of metadherin mediates metastasis of osteosarcoma by regulating epithelial-mesenchymal transition;Tang;Cell Prolif.,2014
4. Different effects of ribosome biogenesis inhibition on cell proliferation in retinoblastoma protein- and p53-deficient and proficient human osteosarcoma cell lines;Montanaro;Cell Prolif.,2007
5. MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma;Zhao;PLoS ONE,2013
Cited by 61 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. MiR-454-3p regulates high glucose-induced mesothelial-mesenchymal transition and glycolysis in peritoneal mesothelial cells by targeting STAT3;Renal Failure;2024-08-27
2. Signal Pathways and microRNAs in Osteosarcoma Growth and the Dual Role of Mesenchymal Stem Cells in Oncogenesis;International Journal of Molecular Sciences;2023-05-19
3. Vascular Niche Facilitates Acquired Drug Resistance to c-Met Inhibitor in Originally Sensitive Osteosarcoma Cells;Cancers;2022-12-15
4. The hepatocyte growth factor/mesenchymal epithelial transition factor axis in high-risk pediatric solid tumors and the anti-tumor activity of targeted therapeutic agents;Frontiers in Pediatrics;2022-08-10
5. miRNAs in Lymphocytic Leukaemias—The miRror of Drug Resistance;International Journal of Molecular Sciences;2022-04-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3